Publication: Production and characterisation of pva/whey protein/hydroxyapatite/gentamicin loaded scaffolds for bone tissue engineering applications
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
3D printing technology is an approach used in health and it can be a pioneer by making progress
in the near future [1]. 3D printers will be of great importance in the production of organs that can replace
diseased or damaged tissues. Bone tissue engineering is an innovative treatment method to treat bone
defects. In this treatment method, healthy tissues are expected to replace damaged tissues for the
treatment of damaged tissues. For healthy tissues to be implanted, they are expected to be biocompatible
and have the same physical, chemical and mechanical properties as damaged tissues [2]. The materials
used should not have a toxic effect on the body, and the materials should also be suitable for printing for
the biofunctional ink of the 3D printer.
In this study, a new approach for bone tissue engineering is considered by using polyvinyl alcohol
(PVA), whey protein isolate (WPI), hydroxyapatite (HA) and gentamicin (GEN). Control group (without
gentamicin), and containing 12 mg gentamicin scaffolds were fabricated with 3D printing technology
and characterisation tests were performed. The characterization of the scaffolds was carried out with
Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-Ray
Diffraction (XRD) and compression test. The average pore sizes of the PVA/WPI/HA and
PVA/WPI/HA/12GEN composite scaffolds was 716.25 ± 101.17 μm and 675.55 ± 60.71 μm,
respectively. With the addition of GEN to composite scaffolds, a decrease in average pore size was
observed. Compression test results showed that the compressive strength decreased from 1.28 MPa to
1.22 MPa with the addition of GEN to the composite scaffolds. Biocompatibility of PVA/WPI/HA and
PVA/WPI/HA/12GEN composite scaffolds was determined with the MTT test. The test results showed
that the fabricated composite scaffolds were non-toxic and cellular growth was provided. Gentamicin
loaded composite scaffolds were successfully fabricated with 3D printing technology. The fabricated
scaffolds have great potential to treat damaged tissue and cells for bone tissue engineering applications.
Description
Keywords
Sağlık Bilimleri, Mühendislik ve Teknoloji, Health Sciences, Engineering and Technology, Klinik Tıp (MED), Mühendislik, Bilişim ve Teknoloji (ENG), Clinical Medicine (MED), Engineering, Computing & Technology (ENG), 3D Printing Technology, Bone Tissue Engineering, Drug Release, Hydroxyapatite, Gentamicin
Citation
Tut T. A., Cesur S., Gündüz O., \"Production and Characterisation of PVA/Whey Protein/Hydroxyapatite/Gentamicin Loaded Scaffolds for Bone Tissue Engineering Applications\", Applications of Chemistry in Nanosciences and Biomaterials Engineering” NanoBioMat 2022 – Summer Edition, Bucuresti, Romanya, 22 - 24 Haziran 2022, ss.1
